Searched for
PHARMA
USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observations- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?
- Sensex rises 200 points, Nifty above 24,300 as oil prices slip ahead of US sanctions on Iran. What to expect?
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...24 Aug, 2026, 08.08 AM IST
- Top sectors in 2026: Pharma and metals race ahead in 2026 so far - check which indices led long-term returnsMetals, real estate, and energy sectors have demonstrated leading long-term investment returns. This TrendMap edition reviews the yearly pe...24 Aug, 2026, 06.30 AM IST
- Stocks in news: Reliance Industries, Bank of Baroda, Power Grid, NATCO Pharma and JSW InfraIndian equity markets closed largely unchanged on Friday, August 21, after a volatile trading session. Several companies, including Relianc...24 Aug, 2026, 06.00 AM IST
- Two killed, nine injured in reactor blast at Telangana pharma unitA reactor blast at a pharma company in Telangana's Yadadri Bhuvanagiri district killed two workers. Nine other individuals sustained injuri...22 Aug, 2026, 07.58 AM IST
- Mankind Pharma inks in-licensing pact with China's Chongqing Chenan BiopharmaceuticalMankind Pharma has secured an exclusive agreement with Chongqing Chenan Biopharmaceutical. This partnership focuses on commercialising two ...20 Aug, 2026, 01.46 PM IST
- Strides Pharma Science shares jump 9% after USFDA EIR for Bengaluru facilityStrides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru fa...20 Aug, 2026, 11.09 AM IST
- Pharma giant Cipla completes merger with wholly-owned subsidiary Inzpera Health SciencesPharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...19 Aug, 2026, 05.52 PM IST
- Dividend alert! Last day to buy Mazagon Dock, Natco Pharma and 13 other stocks for dividends. Do you own any?Mazagon Dock Shipbuilders in April had announced that its board of directors have recommended a final dividend of Rs 4.62 per share for the...19 Aug, 2026, 08.32 AM IST
- NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...18 Aug, 2026, 04.45 PM IST
- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...18 Aug, 2026, 12.36 PM IST
- Lupin gets USFDA nod for generic tablets to treat excessive daytime sleepinessPharma major Lupin Ltd announced receiving final USFDA approval for its generic Pitolisant tablets. These tablets are indicated for treatin...17 Aug, 2026, 01.36 PM IST
- Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDAAurobindo Pharma's US facility received a Voluntary Action Indicated classification. The US FDA closed its inspection of the Raleigh manufa...17 Aug, 2026, 08.59 AM IST
- Natco Pharma Q1 profit falls 57 pc to Rs 206.5 crNatco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalido...14 Aug, 2026, 03.13 PM IST
- Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDAAurobindo Pharma announced its subsidiary Eugia Pharma received a USFDA warning letter. This follows an inspection of their Telangana formu...14 Aug, 2026, 02.02 PM IST
- Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...14 Aug, 2026, 09.06 AM IST
- Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 croreMarksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...12 Aug, 2026, 03.22 PM IST
- Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...11 Aug, 2026, 10.32 AM IST
Load More
